PM01183
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for PM01183, covering 2015-04-01 to 2023-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer. [Phase 1, Phase 2]